Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells

International Immunology

Volumn 14, Issue 3, 2002, Pages 275-286

  Futagawa, Toshiro ^a   Akiba, Hisaya ^a,b   Kodama, Tomohiro ^a,c   Takeda, Kazuyoshi ^a,b   Hosoda, Yasuyuki ^a   Yagita, Hideo ^a,b   Okumura, Ko ^a,b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Co stimulatory molecules; Dendritic cells; Tumor immunity

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 6; LIGAND; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL INTERACTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE;

EID: 0036199305     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/14.3.275     Document Type: Article

References (33)

1. cDNA sequences of two inducible T-cell genes
2. A receptor induced by lymphocyte activation (ILA): A new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family
3. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
4. Molecular and biological characterization of human 4-1BB and its ligand
5. The TNF receptor superfamily of cellular and viral proteins: Activation, co-stimulation, and death
6. Inducible T cell antigen 4-1BB. Analysis of expression and function
7. NK1.1 cells express 4-1BB (CDw137) co-stimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies
8. 4-1BB T-cell antigen binds to mature B cells and macrophages, and co-stimulates anti-mu-primed splenic B cells
9. - T lymphocytes by 4-1BB ligand
10. Role of 4-1BB ligand in co-stimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
11. Potential role of 4-1BB in T cell activation. Comparison with the co-stimulatory molecule CD28
12. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand
13. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
14. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
15. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
16. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
17. Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7
18. CD40-mediated stimulation of B1 and B2 cells: Implication in autoantibody production in murine lupus
19. Characterization of murine CD70 by molecular cloning and mAb
20. + splenic T cells after CD28 receptor ligation
21. GM-CSF-induced in vivo expansion of splenic dendritic cells and their strong co-stimulation activity
22. + dendritic cell population in mouse Peyer's patches
23. - Subclasses of dendritic cells direct the development of distinct T helper cells in vivo
24. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
25. CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes
26. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectional signaling
27. Dendritic cells and the control of immunity
28. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
29. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
30. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
31. + T-cell tolerance to T-cell priming through in vivo ligation of CD40
32. Exogenous CD40 ligand induces a pulmonary inflammation response
33. Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice